Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

09/11/2020 06:30

Nov 9 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended        Year to   
                  Sep 30, 2020        Sep 30, 2019       Dec 31, 2020  
                     LATEST             YEAR-AGO            LATEST     
                     RESULTS             RESULTS           FORECAST    
  Sales              847 mln              2.86               1.04      
                   (-70.4 pct)        (+387.7 pct)       (-67.7 pct)   
  Operating       loss 615 mln            1.36            loss 1.78    
  Recurring       loss 625 mln            1.35            loss 1.79    
  Net             loss 649 mln            1.11            loss 1.82    
  EPS            loss 52.93 yen        104.16 yen      loss 156.45 yen 
  EPS Diluted                          102.07 yen                      
  Ann Div                                  NIL               NIL       
  -Q2 div              NIL                 NIL                         
  -Q4 div                                  NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T